Chris Viehbacher

Biogen isn’t concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
Biogen isn’t concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
CNBC
Biogen
earnings
Pharma CEOs
Chris Viehbacher
Eli Lilly
Alzheimer's disease
Leqembi
donanemab
Flag link:
Biogen chairman to step down as new CEO walks thin line with Alzheimer's launch Leqembi
Biogen chairman to step down as new CEO walks thin line with Alzheimer's launch Leqembi
Fierce Pharma
Biogen
Chris Viehbacher
Stelios Papadopoulos
Pharma CEOs
Alzheimer's disease
Leqembi
Flag link:
New Biogen CEO tips subcutaneous lecanemab to help expansion into pre-symptomatic Alzheimer’s
New Biogen CEO tips subcutaneous lecanemab to help expansion into pre-symptomatic Alzheimer’s
Fierce Pharma
Biogen
Chris Viehbacher
lecanemab
Alzheimer's disease
Pharma CEOs
Flag link:
Biogen appoints ex-Sanofi chief Christopher Viehbacher as CEO
Biogen appoints ex-Sanofi chief Christopher Viehbacher as CEO
Medical Marketing and Media
Biogen
Pharma CEOs
Christopher Viehbacher
Chris Viehbacher
Flag link:
Chris Viehbacher leaps back into biotech as head of Swiss billionaire's $2B fund
Chris Viehbacher leaps back into biotech as head of Swiss billionaire's $2B fund
Fierce Biotech
biotech
Chris Viehbacher
Flag link:
CEO Pay Row at Sanofi AGM
CEO Pay Row at Sanofi AGM
In-Pharma Technologist
Sanofi
executive pay
Olivier Brandicourt
Chris Viehbacher
Flag link:
Ex-Sanofi chief Viehbacher makes a $5M-plus severance deal
Ex-Sanofi chief Viehbacher makes a $5M-plus severance deal
Fierce Pharma
Sanofi
Chris Viehbacher
executive pay
Flag link:
Former Sanofi CEO Viehbacher Says Kickback Allegations Baseless
Former Sanofi CEO Viehbacher Says Kickback Allegations Baseless
Bloomberg
Sanofi
Chris Viehbacher
kickbacks
diabetes
whistleblower lawsuits
Flag link:
Biotech's 3 Most Influential CEOs
Biotech's 3 Most Influential CEOs
Motley Fool
biotech
Ivax
Teva Pharmaceutical
Phillip Frost
OPKO Health
Chris Viehbacher
Sanofi
Gilead Sciences
John C. Martin
Flag link:
Sanofi SA (SNY) Stock On A Decline Since Ousting Of CEO Chris Viehbacher
Sanofi SA (SNY) Stock On A Decline Since Ousting Of CEO Chris Viehbacher
Bidness Etc.
Sanofi
Chris Viehbacher
Flag link:
Digesting Sanofi's Two Pieces Of News- Lantus' Challenging Outlook And The CEO Dismissal
Digesting Sanofi's Two Pieces Of News- Lantus' Challenging Outlook And The CEO Dismissal
Seeking Alpha
Sanofi
Lantus
Chris Viehbacher
Flag link:
Diabetes Analyst: Sanofi CEO's Firing May Spell Trouble for MannKind Afrezza Partnership
Diabetes Analyst: Sanofi CEO's Firing May Spell Trouble for MannKind Afrezza Partnership
TheStreet.com
diabetes
Sanofi
Chris Viehbacher
Flag link:
Chris Viehbacher leaving Sanofi without a U.S.-style windfall
Chris Viehbacher leaving Sanofi without a U.S.-style windfall
Fierce Biotech
Chris Viehbacher
Sanofi
Flag link:
Whither Sanofi? How Easily Can the Drug Maker Find a New CEO?
Whither Sanofi? How Easily Can the Drug Maker Find a New CEO?
WSJ Pharmalot
Sanofi
Pharma CEOs
Chris Viehbacher
Flag link:
Dear Sanofi: Firing CEO Chris Viehbacher Is A Huge Mistake
Dear Sanofi: Firing CEO Chris Viehbacher Is A Huge Mistake
Forbes
Sanofi
Chris Viehbacher
Flag link:
Sanofi CEO Christopher Viehbacher Fired Over Solitary Management Style, Chairman Says
Sanofi CEO Christopher Viehbacher Fired Over Solitary Management Style, Chairman Says
WSJ Online
Sanofi
Pharma CEOs
Chris Viehbacher
Flag link:
Sanofi CEO Asks Board For Explanation Of Rumors Of His Ousting
Sanofi CEO Asks Board For Explanation Of Rumors Of His Ousting
Bidness Etc.
Sanofi
Pharma CEOs
Chris Viehbacher
Flag link:
Sanofi downplays speculation over CEO's future
Sanofi downplays speculation over CEO's future
Seeking Alpha
Sanofi
Chris Viehbacher
Pharma CEOs
Flag link:
What's the gleam in Sanofi CEO's eye? Could be Q2--or a canny PCSK9 maneuver
What's the gleam in Sanofi CEO's eye? Could be Q2--or a canny PCSK9 maneuver
Fierce Pharma
Chris Viehbacher
Sanofi
earnings
Pharma CEOs
PCSK9 inhibitors
Flag link:
Flu season should return Sanofi to double-digit vaccines growth, CEO says
Flu season should return Sanofi to double-digit vaccines growth, CEO says
Fierce Vaccines
Sanofi
Pharma CEOs
Chris Viehbacher
vaccines
Flu
flu vaccines
Flag link:

Pages